Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-analysis of self-controlled case series studies

被引:11
作者
Marchand, Greg [1 ,4 ]
Masoud, Ahmed Taher [1 ,2 ]
Medi, Sai [3 ]
机构
[1] Marchand Inst Minimally Invas Surg, Mesa, AZ USA
[2] Fayoum Univ, Fac Med, Al Fayyum, Egypt
[3] Swedish Med Ctr, Englewood, CO USA
[4] Marchand Inst Minimally Invas Surg, 10238 E Hampton, Ste 212, Mesa, AZ 85209 USA
关键词
COVID19; vaccination; all-cause mortality; cardiac mortality; mRNA vaccination; self controlled case series; meta-analysis; ADOLESCENTS; MYOCARDITIS; SAFETY; US;
D O I
10.1080/21645515.2023.2230828
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Self-controlled case series (SCCS) is a novel study design uniquely equipped to ethically quantify the safety of vaccination. We sought out to perform a meta-analysis on all SCCS assessing mortality associated with COVID-19 vaccination in the immediate post-vaccination period. We included SCCS investigating the safety of COVID-19 vaccination and reporting all-cause and cardiac-related mortality. Three SCCS were located, totaling approximately 750,000 patients. The pooled hazard ratio (HR) revealed no significant association of COVID-19 vaccination with all-cause mortality (HR = 0.89, 95% CI [0.71, 1.10], p = .28). Regarding cardiac-related mortality, the pooled HR suggests that COVID-19 vaccination is associated with an increased risk of cardiac-related mortality (HR = 1.06, 95% CI [1.02, 1.11], p = .007). Subgroup analysis showed that the male gender is significantly associated with an increased incidence of cardiac-related deaths (HR = 1.09, 95% CI [1.02, 1.15], p = .006). In conclusion, COVID-19 vaccination may be associated with a small increase in cardiac-related mortality, especially among males. Prospero Prospective Registration Number: CRD42022372256
引用
收藏
页数:6
相关论文
共 32 条
[1]  
Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1056/NEJMoa2119451, 10.1016/S1473-3099(22)00309-7]
[2]  
[Anonymous], 2021, BBC News
[3]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[4]   Adverse events following mRNA SARS-CoV-2 vaccination among US nursing home residents [J].
Bardenheier, Barbara H. ;
Gravenstein, Stefan ;
Blackman, Carolyn ;
Gutman, Roee ;
Sarkar, Indra Neil ;
Feifer, Richard A. ;
White, Elizabeth M. ;
McConeghy, Kevin ;
Nanda, Aman ;
Mor, Vincent .
VACCINE, 2021, 39 (29) :3844-3851
[5]   Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study [J].
Bernal, Jamie Lopez ;
Andrews, Nick ;
Gower, Charlotte ;
Robertson, Chris ;
Stowe, Julia ;
Tessier, Elise ;
Simmons, Ruth ;
Cottrell, Simon ;
Roberts, Richard ;
O'Doherty, Mark ;
Brown, Kevin ;
Cameron, Claire ;
Stockton, Diane ;
McMenamin, Jim ;
Ramsay, Mary .
BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
[6]   Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol? [J].
Cabanillas, Beatriz ;
Akdis, Cezmi A. ;
Novak, Natalija .
ALLERGY, 2021, 76 (06) :1617-1618
[7]   A Nursing Researcher's Experience in a COVID-19 Vaccine Trial [J].
Choi, Kristen R. .
JAMA INTERNAL MEDICINE, 2021, 181 (02) :157-158
[8]  
community.cochrane.org, REVMAN 5 COCHR COMM
[9]   Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age [J].
Das, Bibhuti B. ;
Kohli, Utkarsh ;
Ramachandran, Preeti ;
Nguyen, Hoang H. ;
Greil, Gerald ;
Hussain, Tarique ;
Tandon, Animesh ;
Kane, Colin ;
Avula, Sravani ;
Duru, Chioma ;
Hede, Sannya ;
Sharma, Kavita ;
Chowdhury, Devyani ;
Patel, Sunil ;
Mercer, Christopher ;
Chaudhuri, Nita Ray ;
Patel, Bhavi ;
Ang, Jocelyn Y. ;
Asmar, Basim ;
Sanchez, Joselito ;
Khan, Danyal .
JOURNAL OF PEDIATRICS, 2021, 238 :26-32
[10]   Control without separate controls: evaluation of vaccine safety using case-only methods [J].
Farrington, CP .
VACCINE, 2004, 22 (15-16) :2064-2070